No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma.

No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma. — المؤلف: Saeki, Issei — Liver cancer Oct 2018

المؤلف
Saeki, Issei
النشر
Liver cancer Oct 2018
الوصف
359-371 p.